Targeted Screening for Taenia Solium Tapeworms

Not Applicable

Completed

• Conditions: Taenia Solium Taeniasis
• Interventions: Drug: Niclosamide; Behavioral: Community education campaign

• Registration Number: NCT01296958
• Lead Sponsor: Oregon Health and Science University

Brief Summary

The purpose of this study is to determine whether screening and treatment of tapeworm carriers can decrease community transmission of Taenia solium parasitic infection.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2011-02-15
• Study First Submitted QC: 2011-02-15
• Study First Posted: 2011-02-16
• Study Start: 2011-05
• Primary Completion: 2013-01
• Study Completion: 2013-01
• Status Verified: 2014-10
• Last Update Submitted: 2014-10-22
• Last Update Posted: 2014-10-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1811

Inclusion Criteria

• All community members are eligible

Exclusion Criteria

• Inability to provide informed consent

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Targeted screening	Niclosamide	Screening for intestinal tapeworm carrier followed by treatment with niclosamide as indicated.
Education	Community education campaign	Community education about Taenia solium prevention.

Primary Outcome Measures

Name	Time	Method
Porcine seroprevalence	Every 4 months

Secondary Outcome Measures

Name	Time	Method
Intestinal tapeworm prevalence	16 months

Trial Locations

Locations (1)

San Marcos University; 🇵🇪 Lima, Peru